Navigation Links
Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan

LONDON, Aug. 24 /PRNewswire/ -- While the penetration of picture archiving and communication systems (PACS) in European hospitals is 80 per cent, the modern radiology information system (RIS) that drives PACS has only reached a penetration level of about 41 per cent. Legacy RIS modules ubiquitously dominate the market and many hospitals are reluctant to install a new RIS due to complications associated with training a large group of staff as well as concerns over data migration and security. However, with the third generation of PACS installations, hospitals have realised the importance of investing in a modern RIS. Moreover, they are also recognising the need to purchase RIS and PACS from the same vendor to reduce operational costs.



New analysis from Frost & Sullivan (, European RIS/PACS Market, finds that the market was valued at $679.4 million in 2009 and estimates this to reach $1,353.3 million in 2016.

"Expanding regulatory initiatives of DICOM and HL7 will make the homegrown RIS solution obsolete, thereby boosting RIS installations from prominent vendors," notes Frost & Sullivan Programme Manager Eramangalath Sujith. "The new slipstream of advanced PACS installations will require hospitals to have a modern RIS system that will drive these PACS."

Old RIS modules are unidirectional systems incapable of driving PACS modules. Unidirectional systems will also lead to unnecessary duplication of data, thereby adding to the operational cost of hospitals. Modern RIS and PACS installations will ensure a single-point desktop access to radiology information and digitised images. This will support enhanced productivity.

The major challenge faced by the RIS/PACS industry is related to people. Hospital staff have been used to legacy RIS modules that have existed for more than 20 years. For a long time, hospitals were only concerned with allocating budgets for PACS installations and making their IT portfolio complete.

"RIS systems used to cost as much as PACS systems about five to six years ago," explains Sujith. "European hospitals allocated budgets only for PACS purchase and not for RIS."

As most RIS and PACS modules are sold separately, hospitals can save between 10-20 per cent (depending on their preliminary requirements) of the total price on their initial RIS/PACS installation. An even more important criterion promoting system adoption is the prospect of reduced operational cost during the long term.

"Vendors for RIS and PACS modules should justify faster return on investments to clients through the purchase of both modules as a combined package," advises Sujith.

If you are interested in more information on Frost & Sullivan's latest study on the European RIS/PACS Market, please send an e-mail to Katja Feick, Corporate Communications, at, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European RIS/PACS Market is part of the Medical Imaging Growth Partnership Services programme, which also includes research in the following markets: European Laboratory Information Systems, European C-Arms Market and, Strategic Outlook into Archive Requirements for Digitised Images in Medical Imaging. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit RIS/PACS Market (M564)Contact:Katja FeickCorporate Communications – EuropeP: +49 (0) 69 7703343E: katja.feick@frost.comhttp://www.frost.comTwitter:

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
2. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
3. Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia
4. Younger Adults Increasingly Treated for Heart Disease-related Conditions
5. Increasing Dairy Milk Production with Electrolyzed Drinking Water
6. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
7. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
8. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
9. Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
10. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
11. Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations
Post Your Comments:
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):